What is the significance and what is the most important concept from your study for readers? What are the implications? Each submission must include an uploaded file outlining the contribution(s) that each author made toward the production of

the article. Generic drug names should be used; trade names may be inserted in parentheses after the initial mention of the drug. Product names should be treated similarly, listing the manufacturer’s name, city, and state in parentheses. Do not put product or drug names in the title or the abstract of the article. Laboratory values should be presented in SI units. For conversion from non-SI units see http://www.techexpo.com/techdata/techcntr.html. After laboratory values, KU-60019 clinical trial normal values should be presented TSA HDAC manufacturer in parentheses in the text. A separate Word file listing all abbreviations and acronyms will need to be uploaded during the submission process. Spell out abbreviations and acronyms the first time the terms appear in the text. You may follow the list of standard abbreviations found in the AMA Manual of Style, 10th edition. 6 All studies reporting levels of significance must include the sample size calculation and power used in that calculation. Justification for deviating from calculated sample sizes must be addressed.

Figures (including color photographs) are published without charge to authors. • Instructions for creating figures can be found below and at ees.elsevier.com/gie. Videos and computer graphics (ie, slide presentations with or without animation) can be submitted through EES. If the file is too large to upload into EES, please email the GIE Editorial Office at [email protected] for special uploading instructions. Please indicate the video component on Clomifene the submission cover page. References must be cited in the text in consecutive order and identified by superscript numbers. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. These permissions must be submitted to the

Editorial Office before publication can occur. The Editorial Office and Elsevier may choose to publish an article online before we publish it in the journal. Please contact our production department immediately if you do not want us to make any such prior publication for any reason, including disclosure of a patentable invention. Galley proofs are e-mailed to the corresponding author and must be returned to the publisher by fax or e-mail within 48 hours to avoid delay in publication. John Porter Journal Manager Elsevier Inc. 360 Park Avenue South New York, NY 10010-1710 Fax: 212-462-1955 E-mail: [email protected] For any further information please contact the Journal Manager or the Author Support Department at authorsupport@elsevier.